𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biology of multiple myeloma—host-tumour interactions and immune regulation of disease activity

✍ Scribed by D. E. Joshua

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
427 KB
Volume
6
Category
Article
ISSN
0278-0232

No coin nor oath required. For personal study only.

✦ Synopsis

Multiple myeloma is a B lineage tumour, the neoplastic cells of which secrete a monoclonal idiotypic paraprotein and have a characteristic plasma B cell surface antigen expression, i.e. CIg+ ,

📜 SIMILAR VOLUMES

Multiple myeloma: A prototypic disease m
Multiple myeloma: A prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment
✍ Constantine S. Mitsiades; Nicholas S. Mitsiades; Paul G. Richardson; Nikhil C. M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

## Abstract The interaction between tumor cells and the local milieu where are homing has recently become the focus of extensive research in a broad range of malignancies. Among them, multiple myeloma (MM) is now recognized as a prototypical tumor model for the characterization of these interaction

Elevated serum concentration of hepatocy
Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: Correlation with markers of disease activity
✍ M.G. Alexandrakis; F.H. Passam; A. Sfiridaki; E. Kandidaki; P. Roussou; D.S. Kyr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Abstract Hepatocyte growth factor (HGF) has been shown to be involved in angiogenesis, epithelial cell proliferation, and osteoclast activation. HGF and its receptor are expressed on myeloma cell lines and could be involved in the pathogenesis of bone destruction in multiple myeloma (MM). The ai

Urinary N-telopeptide levels in multiple
Urinary N-telopeptide levels in multiple myeloma patients, correlation with Tc-99m-sestaMIBI scintigraphy and other biochemical markers of disease activity
✍ M. G. Alexandrakis; D. S. Kyriakou; F. H. Passam; N. Malliaraki; I. G. Vlachonik 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract Urinary cross‐linked N‐telopeptide of type I collagen (NTx) has been reported to be a sensitive and specific marker of bone resorption in multiple myeloma (MM). In this study, we measured the levels of NTx in 30 newly diagnosed MM patients and 25 controls. We examined its association wi